Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon

Completed · Not applicable

Conditions studied: Peripheral Arterial Disease

In brief

This study is designed to evaluate the safety and efficacy of a Paclitaxel-coated percutaneous transluminal angioplasty (PTA) Catheter in the treatment of patients with peripheral arterial disease.

Key facts

Study ID
NCT01858428
Run by
Spectranetics Corporation
People needed
300
Starts
2013-06-18
Expected to finish
2018-03-19
Last updated by the study team
2020-08-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.